Izotropic Corporation (CSE:IZO)

Market Cap	15.23M +143.8%
Revenue (ttm)	n/a
Net Income	-2.75M
EPS	-0.04
Shares Out	69.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,600
Average Volume	57,903
Open	0.2250
Previous Close	0.2200
Day's Range	0.2150 - 0.2300
52-Week Range	0.1900 - 0.4900
Beta	2.54
RSI	43.26
Earnings Date	Apr 2, 2026

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO